Price Chart

Key Stats

Customize
Expense Ratio Discount or Premium to NAV Total Assets Under Management 30-Day Average Daily Volume
0.75% 0.70% 70.06M 2609.57
Dividend Yield Turnover Ratio 1 Year Fund Level Flows Max Drawdown (All)
5.69% 85.35% 5.750M Upgrade

Basic Info

Investment Strategy
The investment objectives of Brompton Global Healthcare Income & Growth ETF are to provide holders of Units (“Unitholders”) of the Brompton ETF with: (a) stable monthly cash distributions; (b) the opportunity for capital appreciation; and (c) lower overall volatility of portfolio returns than would otherwise be experienced by owning securities of Healthcare Companies (as defined herein) directly. The Brompton ETF seeks to hedge substantially all of its direct exposure to foreign currencies back to the Canadian dollar. However, any exposure that the Brompton ETF’s assets allocable to the USD Units have to foreign currencies will not be hedged.
General
Security Type Exchange-Traded Fund
Equity Style Large Cap/Growth
Fixed Income Style --
Broad Asset Class --
Broad Category Equity
Category Name Sector Equity
Category Index Morningstar Gbl Mkts GR CAD
Prospectus Objective --
Fund Owner Firm Name Brompton Funds Limited
Prospectus Benchmark Index
MSCI World Health Care GR 100.0%
Broad Asset Class Benchmark Index
^SPTSX60TR 100.0%
Manager Tenure
Not Disclosed 6.02 yrs

Net Fund Flows Versus Category

View Net Fund Flows. Upgrade now.
1M
3M
6M
YTD
1Y
3Y
5Y
10Y
 
80.00B
60.00B
40.00B
20.00B
0
-20.00B
1 Month
% Rank: --
-- Category Low
-- Category High
1 Year
% Rank: 77
5.750M
-160.81M Category Low
1.447B Category High
3 Months
% Rank: --
-- Category Low
-- Category High
3 Years
% Rank: --
-- Category Low
-- Category High
6 Months
% Rank: --
-- Category Low
-- Category High
5 Years
% Rank: --
-- Category Low
-- Category High
YTD
% Rank: --
-- Category Low
-- Category High
10 Years
% Rank: --
-- Category Low
-- Category High
As of September 30, 2021

Performance Versus Category

 
20%
15%
10%
5%
0
View Category Returns. Upgrade now.
Name
1M
3M
YTD
1Y
3Y
5Y
10Y
15Y
Total Return (Price)
--
--
--
--
--
--
--
--
Total Return (NAV)
--
--
--
--
--
--
--
--
Category Rtn. (NAV)
--
--
--
--
--
--
--
--
% Rank in Cat (NAV)
--
--
--
--
--
--
--
--
As of October 18, 2021. Returns for periods of 1 year and above are annualized.

Annual Total Returns Versus Peers

Edit comparables
Loading chart...
Name
2014
2015
2016
2017
2018
2019
2020
YTD
--
--
--
--
--
24.04%
5.03%
14.32%
12.27%
-7.76%
21.36%
9.78%
-7.58%
21.93%
5.56%
24.70%
--
--
--
--
--
--
17.53%
8.82%
34.72%
6.77%
-5.04%
25.34%
-2.86%
26.00%
21.65%
11.43%
--
--
--
--
--
23.54%
6.08%
14.16%
--
--
--
--
--
--
--
--
As of October 18, 2021.

Fundamentals

General
Distribution Yield Upgrade
Dividend Yield TTM (10-18-21) 5.69%
30-Day SEC Yield --
7-Day SEC Yield --
Number of Holdings Upgrade
Stock
Weighted Average PE Ratio 35.25
Weighted Average Price to Sales Ratio Upgrade
Weighted Average Price to Book Ratio Upgrade
Weighted Median ROE Upgrade
Weighted Median ROA Upgrade
Forecasted Dividend Yield Upgrade
Forecasted PE Ratio Upgrade
Forecasted Price to Sales Ratio Upgrade
Forecasted Price to Book Ratio Upgrade
As of September 30, 2021

Growth Estimates

Forecasted 5 Yr Earnings Growth Upgrade
Forecasted Book Value Growth Upgrade
Forecasted Cash Flow Growth Upgrade
Forecasted Earnings Growth Upgrade
Forecasted Revenue Growth Upgrade
As of September 30, 2021

Asset Allocation

As of September 30, 2021.
Type % Net % Long % Short
Cash 0.61% Upgrade Upgrade
Stock 99.39% Upgrade Upgrade
Bond 0.00% Upgrade Upgrade
Convertible 0.00% Upgrade Upgrade
Preferred 0.00% Upgrade Upgrade
Other 0.00% Upgrade Upgrade

Top 10 Holdings

Name % Weight Price % Change
Agilent Technologies Inc 4.98% 154.78 0.99%
IDEXX Laboratories Inc 4.88% 638.29 0.49%
Danaher Corp 4.35% 304.18 0.93%
Novo Nordisk A/S ADR 4.20% 103.43 1.07%
Intuitive Surgical Inc 4.19% 332.30 0.24%
Straumann Holding AG
3.98% -- --
Thermo Fisher Scientific Inc 3.93% 588.03 0.97%
HCA Healthcare Inc 3.93% 246.59 -0.12%
Zoetis Inc Class A 3.83% 202.73 0.25%
Edwards Lifesciences Corp 3.83% 111.09 -0.95%

News

Headline
Wire
Time (ET)

Basic Info

Investment Strategy
The investment objectives of Brompton Global Healthcare Income & Growth ETF are to provide holders of Units (“Unitholders”) of the Brompton ETF with: (a) stable monthly cash distributions; (b) the opportunity for capital appreciation; and (c) lower overall volatility of portfolio returns than would otherwise be experienced by owning securities of Healthcare Companies (as defined herein) directly. The Brompton ETF seeks to hedge substantially all of its direct exposure to foreign currencies back to the Canadian dollar. However, any exposure that the Brompton ETF’s assets allocable to the USD Units have to foreign currencies will not be hedged.
General
Security Type Exchange-Traded Fund
Equity Style Large Cap/Growth
Fixed Income Style --
Broad Asset Class --
Broad Category Equity
Category Name Sector Equity
Category Index Morningstar Gbl Mkts GR CAD
Prospectus Objective --
Fund Owner Firm Name Brompton Funds Limited
Prospectus Benchmark Index
MSCI World Health Care GR 100.0%
Broad Asset Class Benchmark Index
^SPTSX60TR 100.0%
Manager Tenure
Not Disclosed 6.02 yrs

Fundamentals

General
Distribution Yield Upgrade
Dividend Yield TTM (10-18-21) 5.69%
30-Day SEC Yield --
7-Day SEC Yield --
Number of Holdings Upgrade
Stock
Weighted Average PE Ratio 35.25
Weighted Average Price to Sales Ratio Upgrade
Weighted Average Price to Book Ratio Upgrade
Weighted Median ROE Upgrade
Weighted Median ROA Upgrade
Forecasted Dividend Yield Upgrade
Forecasted PE Ratio Upgrade
Forecasted Price to Sales Ratio Upgrade
Forecasted Price to Book Ratio Upgrade
As of September 30, 2021

Growth Estimates

Forecasted 5 Yr Earnings Growth Upgrade
Forecasted Book Value Growth Upgrade
Forecasted Cash Flow Growth Upgrade
Forecasted Earnings Growth Upgrade
Forecasted Revenue Growth Upgrade
As of September 30, 2021

Fund Details

Key Dates
Inception Date 9/24/2015
Last Annual Report Date 12/31/2020
Last Prospectus Date 3/26/2021
Attributes
Enhanced Index Fund No
Index Fund No
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan No
Socially Responsible Fund No

News

Headline
Wire
Time (ET)